BI-905711
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BI-905711, covering 2025-02-19 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer [Phase 1]